Taisho Pharmaceutical Holdings Co., Ltd.

OTCPK:TAIP.Y Rapporto sulle azioni

Cap. di mercato: US$4.6b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Taisho Pharmaceutical Holdings Gestione

Gestione criteri di controllo 3/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Akira Uehara

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO11.1yrs
Proprietà del CEOn/a
Durata media del management10.1yrs
Durata media del Consiglio di amministrazione5.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Akira Uehara rispetto agli utili di Taisho Pharmaceutical Holdings?
DataCompenso totaleStipendioGuadagni aziendali
Dec 31 2023n/an/a

JP¥8b

Sep 30 2023n/an/a

JP¥16b

Jun 30 2023n/an/a

JP¥18b

Mar 31 2023n/an/a

JP¥19b

Dec 31 2022n/an/a

JP¥25b

Sep 30 2022n/an/a

JP¥21b

Jun 30 2022n/an/a

JP¥18b

Mar 31 2022JP¥113mJP¥102m

JP¥13b

Dec 31 2021n/an/a

JP¥8b

Sep 30 2021n/an/a

JP¥5b

Jun 30 2021n/an/a

JP¥8b

Mar 31 2021JP¥119mJP¥100m

JP¥13b

Dec 31 2020n/an/a

JP¥17b

Sep 30 2020n/an/a

JP¥17b

Jun 30 2020n/an/a

JP¥16b

Mar 31 2020JP¥111mJP¥97m

JP¥21b

Dec 31 2019n/an/a

JP¥15b

Sep 30 2019n/an/a

JP¥21b

Jun 30 2019n/an/a

JP¥46b

Mar 31 2019JP¥116mJP¥94m

JP¥49b

Compensazione vs Mercato: Insufficient data to establish whether Akira's total compensation is reasonable compared to companies of similar size in the US market.

Compensazione vs guadagni: Akira's compensation has been consistent with company performance over the past year.


AMMINISTRATORE DELEGATO

Akira Uehara (83 yo)

11.1yrs

Mandato

JP¥113,000,000

Compensazione

Mr. Akira Uehara has been the Chief Executive Officer at Taisho Pharmaceutical Holdings Co., Ltd since July2013. Mr. Uehara served as Chairman of Taisho Pharmaceutical Co., Ltd until December 30, 2015 and...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Akira Uehara
CEO & Representative Director11.1yrsJP¥113.00mNessun dato
Shigeru Uehara
Executive VP & Director9.1yrsJP¥123.00m0%
¥ 0
Shinichi Tanaka
General Manager of Corporate Communicationsno dataNessun datoNessun dato
Ken Uehara
MD & Executive Director12.8yrsJP¥105.00m0%
¥ 0
Tetsu Watanabe
Executive Directorno dataNessun dato0%
¥ 0
Jun Kuroda
Executive VP & Director3.1yrsNessun dato0%
¥ 0

10.1yrs

Durata media

Gestione esperta: TAIP.Y's management team is seasoned and experienced (10.1 years average tenure).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Akira Uehara
CEO & Representative Directorno dataJP¥113.00mNessun dato
Shigeru Uehara
Executive VP & Director17.1yrsJP¥123.00m0%
¥ 0
Ken Uehara
MD & Executive Director11.1yrsJP¥105.00m0%
¥ 0
Tetsu Watanabe
Executive Director9.1yrsNessun dato0%
¥ 0
Jun Kuroda
Executive VP & Director3.1yrsNessun dato0%
¥ 0
Takeshi Kunibe
Independent Outside Director5.5yrsNessun dato0%
¥ 0
Makoto Matsuo
Audit & Supervisory Board Member4.1yrsNessun dato0%
¥ 0
Kazuya Kameo
Audit & Supervisory Board Member5.5yrsNessun dato0%
¥ 0
Chushiro Aoi
Outside Audit & Supervisory Board Member9.1yrsNessun datoNessun dato
Osamu Kitatani
Director3.5yrsNessun dato0%
¥ 0
Takeshi Ikoma
Audit & Supervisory Board Member3.1yrsNessun dato0%
¥ 0

5.5yrs

Durata media

72.5yo

Età media

Consiglio di amministrazione esperto: TAIP.Y's board of directors are considered experienced (5.5 years average tenure).